LBT Innovations Limited (ASX:LBT)
LBT Innovations Limited (ASX:LBT) is a designer of advanced technology solutions for the medical industry.
The Company's first product, MicroStreak, was a global first in the automation of the culture plate streaking process.
The Companys second product, the Automated Plate Assessment System (APAS) is based upon LBTs intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis and interpretation of culture plates following incubation.
APAS is being commercialised through Clever Culture Systems, a JV between LBT and Hettich Holding Beteiligungs-und Verwaltungs-GmbH. Beckman Coulter have also been appointed as Marketing Agent in Europe drive sales.